Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
Joseph Tripodi1, Ronald Hoffman1, Vesna Najfeld2, Rona Weinberg31The Myeloproliferative Disorders Program, Tisch Cancer Institute, Department of Medicine and 2Department of Medicine and Pathology, Mount Sinai School of Medicine, 3The Myeloproliferative Disorders Program, Cellular Therapy Laboratory,...
Main Authors: | Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-09-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/frequency-of-heterozygous-tet2-deletions-in-myeloproliferative-neoplas-a5301 |
Similar Items
-
FREQUENCY OF TET2 GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
by: Syed Owais Ali, et al.
Published: (2021-04-01) -
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasms.
by: Wanlong Ma, et al.
Published: (2010-01-01) -
TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings
by: Andrea Patriarca, et al.
Published: (2013-01-01) -
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
by: Davis, A., et al.
Published: (2022) -
Aetiology of Myeloproliferative Neoplasms
by: Mary Frances McMullin, et al.
Published: (2020-07-01)